Biricodar or incel (INN, codename VX-710) was a pharmaceutical drug under development by Vertex Pharmaceuticals to help treat ovarian cancer patients, that never reached the market.
![]() | |
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number | |
Chemical and physical data | |
Formula | C34H41N3O7 |
Molar mass | 603.716 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
External links
edit